USD26.47
https://img.lazcdn.com/g/p/75ce8f336208e4ecad9a2a8a1a05c2e7.jpg_720x720q80.jpg 10.1210/mend-3-6-1014 Treatment:1 Month sterile water injection Novo Nordisk's stock drops despite CagriSema hitting goal of Phase III trial - Clinical Trials Arena
USD26.47
USD27.77